We performed RT-qPCR to measure the expression of GAPLINC in osteosarcoma clinical samples and cell lines, and found that levels of GAPLINC expression were increased in osteosarcoma clinical samples and cell lines compared with adjacent non-cancerous normal tissues and human normal osteoblast cell line, respectively. The gene discussed is GAPLINC; the disease is osteosarcoma.